Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07477197 · ClinicalTrials.gov registry record
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
A clinical trial of Pulmonary Hypertension and Adult Congenital Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT07477197 is a study of Pulmonary Hypertension and Adult Congenital Heart Disease that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 5,000 participants, above the 544-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (819% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07477197, a study of Pulmonary Hypertension and Adult Congenital Heart Disease, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of patient experience and functional status; associations between clinical characteristics and various biomarkers; and predictors of clinical outcomes.
Conditions Studied
Study Locations (1)
Ohio
- Children's Hospital Medical Center, Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2050-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07477197
The ClinicalTrials.gov registry entry for NCT07477197 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 544-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (819% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT07477197 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07477197 about?
NCT07477197 is a clinical study titled "Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders". A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of p...
What is the current status of trial NCT07477197?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2021-07-01. Estimated completion is 2050-01-01.
What conditions does trial NCT07477197 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Adult Congenital Heart Disease, Connective Tissue Disease, Other Cardiovascular Conditions.
Who is sponsoring clinical trial NCT07477197?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07477197 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
-
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.